Birdwatch Note
2024-04-14 09:20:26 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Juneve não é um medicamento genérico, é um bio similar. Medicamentos genéricos NÃO TEM marca vinculada, apenas o nome do princípio ativo e uma grande faixa amarela com uma letra G em destaque e escrito "Medicamento Genérico" seguindo a legislação brasileira. https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/genericos
Written by CF189F062D0FEEC430DDCABBA38B75F475DB91D7D8CC55D7FAFA7794D3BE8854
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1779170061053247714
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1779439563309531182
- noteId - 1779439563309531182
- participantId -
- noteAuthorParticipantId - CF189F062D0FEEC430DDCABBA38B75F475DB91D7D8CC55D7FAFA7794D3BE8854 Participant Details
- createdAtMillis - 1713086426940
- tweetId - 1779170061053247714
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 1
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Juneve não é um medicamento genérico, é um bio similar. Medicamentos genéricos NÃO TEM marca vinculada, apenas o nome do princípio ativo e uma grande faixa amarela com uma letra G em destaque e escrito "Medicamento Genérico" seguindo a legislação brasileira. https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/genericos
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-04-14 09:20:26 UTC (1713086426940) |
2024-04-14 13:52:32 UTC (1713102752370) |
CURRENTLY_RATED_HELPFUL | 2024-04-15 04:12:13 UTC (1713154333742) |
CURRENTLY_RATED_HELPFUL | 2024-04-14 13:52:32 UTC (1713102752370) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-04-14 12:58:30 -0500 | Rating Details | |
| 2024-04-14 08:53:53 -0500 | Rating Details | |
| 2024-04-14 08:52:55 -0500 | Rating Details | |
| 2024-04-14 08:41:45 -0500 | Rating Details | |
| 2024-04-14 08:41:35 -0500 | Rating Details | |
| 2024-04-14 08:39:40 -0500 | Rating Details | |
| 2024-04-14 08:06:22 -0500 | Rating Details | |
| 2024-04-14 08:00:15 -0500 | Rating Details | |
| 2024-04-14 07:40:27 -0500 | Rating Details | |
| 2024-04-14 07:30:11 -0500 | Rating Details | |
| 2024-04-14 07:28:17 -0500 | Rating Details | |
| 2024-04-14 07:27:49 -0500 | Rating Details | |
| 2024-04-14 07:24:13 -0500 | Rating Details | |
| 2024-04-14 07:17:26 -0500 | Rating Details | |
| 2024-04-14 07:08:51 -0500 | Rating Details | |
| 2024-04-14 06:58:08 -0500 | Rating Details | |
| 2024-04-14 06:44:20 -0500 | Rating Details | |
| 2024-04-14 06:10:58 -0500 | Rating Details | |
| 2024-04-14 06:10:28 -0500 | Rating Details | |
| 2024-04-14 05:19:21 -0500 | Rating Details | |
| 2024-04-19 16:16:01 -0500 | Rating Details | |
| 2024-04-14 10:28:48 -0500 | Rating Details | |
| 2024-04-14 10:11:17 -0500 | Rating Details | |
| 2024-04-14 09:37:22 -0500 | Rating Details | |
| 2024-04-14 09:16:41 -0500 | Rating Details | |
| 2024-04-14 09:05:15 -0500 | Rating Details | |
| 2024-04-14 08:56:27 -0500 | Rating Details | |
| 2024-04-14 08:25:12 -0500 | Rating Details | |
| 2024-04-14 08:19:35 -0500 | Rating Details | |
| 2024-04-14 07:32:13 -0500 | Rating Details | |
| 2024-04-14 07:31:58 -0500 | Rating Details | |
| 2024-04-14 07:21:01 -0500 | Rating Details | |
| 2024-04-14 06:58:22 -0500 | Rating Details | |
| 2024-04-14 06:40:18 -0500 | Rating Details | |
| 2024-04-14 06:16:17 -0500 | Rating Details | |
| 2024-04-14 05:43:10 -0500 | Rating Details | |
| 2024-04-14 05:34:57 -0500 | Rating Details | |
| 2024-04-14 05:06:17 -0500 | Rating Details | |
| 2024-04-14 05:04:10 -0500 | Rating Details | |
| 2024-04-14 04:43:17 -0500 | Rating Details | |
| 2024-04-14 09:24:41 -0500 | Rating Details | |
| 2024-04-15 18:24:01 -0500 | Rating Details | |
| 2024-04-14 19:37:37 -0500 | Rating Details | |
| 2024-04-14 18:24:05 -0500 | Rating Details | |
| 2024-04-14 11:57:23 -0500 | Rating Details | |
| 2024-04-14 10:49:38 -0500 | Rating Details | |
| 2024-04-14 10:39:16 -0500 | Rating Details | |
| 2024-04-14 09:26:35 -0500 | Rating Details | |
| 2024-04-14 09:19:27 -0500 | Rating Details | |
| 2024-04-14 09:01:14 -0500 | Rating Details | |
| 2024-04-14 08:51:58 -0500 | Rating Details | |
| 2024-04-14 08:38:01 -0500 | Rating Details | |
| 2024-04-14 08:23:25 -0500 | Rating Details | |
| 2024-04-14 08:13:40 -0500 | Rating Details | |
| 2024-04-14 08:08:03 -0500 | Rating Details | |
| 2024-04-14 08:04:14 -0500 | Rating Details | |
| 2024-04-14 08:03:43 -0500 | Rating Details | |
| 2024-04-14 07:55:54 -0500 | Rating Details | |
| 2024-04-14 07:51:11 -0500 | Rating Details | |
| 2024-04-14 07:32:04 -0500 | Rating Details | |
| 2024-04-14 07:18:21 -0500 | Rating Details | |
| 2024-04-14 07:18:21 -0500 | Rating Details | |
| 2024-04-14 07:01:00 -0500 | Rating Details | |
| 2024-04-14 06:53:16 -0500 | Rating Details | |
| 2024-04-14 06:49:28 -0500 | Rating Details | |
| 2024-04-14 06:28:44 -0500 | Rating Details | |
| 2024-04-14 05:12:57 -0500 | Rating Details | |
| 2024-04-14 04:58:44 -0500 | Rating Details | |
| 2024-04-14 04:54:34 -0500 | Rating Details | |
| 2024-05-02 11:07:54 -0500 | Rating Details |